Literature DB >> 22032986

Diversity and modularity of G protein-coupled receptor structures.

Vsevolod Katritch1, Vadim Cherezov, Raymond C Stevens.   

Abstract

G protein-coupled receptors (GPCRs) comprise the most 'prolific' family of cell membrane proteins, which share a general mechanism of signal transduction, but greatly vary in ligand recognition and function. Crystal structures are now available for rhodopsin, adrenergic, and adenosine receptors in both inactive and activated forms, as well as for chemokine, dopamine, and histamine receptors in inactive conformations. Here we review common structural features, outline the scope of structural diversity of GPCRs at different levels of homology, and briefly discuss the impact of the structures on drug discovery. Given the current set of GPCR crystal structures, a distinct modularity is now being observed between the extracellular (ligand-binding) and intracellular (signaling) regions. The rapidly expanding repertoire of GPCR structures provides a solid framework for experimental and molecular modeling studies, and helps to chart a roadmap for comprehensive structural coverage of the whole superfamily and an understanding of GPCR biological and therapeutic mechanisms.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22032986      PMCID: PMC3259144          DOI: 10.1016/j.tips.2011.09.003

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  84 in total

1.  Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists.

Authors:  Beili Wu; Ellen Y T Chien; Clifford D Mol; Gustavo Fenalti; Wei Liu; Vsevolod Katritch; Ruben Abagyan; Alexei Brooun; Peter Wells; F Christopher Bi; Damon J Hamel; Peter Kuhn; Tracy M Handel; Vadim Cherezov; Raymond C Stevens
Journal:  Science       Date:  2010-10-07       Impact factor: 47.728

Review 2.  G protein-coupled receptors: novel targets for drug discovery in cancer.

Authors:  Rosamaria Lappano; Marcello Maggiolini
Journal:  Nat Rev Drug Discov       Date:  2011-01       Impact factor: 84.694

3.  Identification of an antithrombotic allosteric modulator that acts through helix 8 of PAR1.

Authors:  Louisa Dowal; Derek S Sim; James R Dilks; Price Blair; Sarah Beaudry; Bradley M Denker; Georgios Koukos; Athan Kuliopulos; Robert Flaumenhaft
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-31       Impact factor: 11.205

Review 4.  Evolution of GPCR: change and continuity.

Authors:  Rainer Strotmann; Kristin Schröck; Iris Böselt; Claudia Stäubert; Andreas Russ; Torsten Schöneberg
Journal:  Mol Cell Endocrinol       Date:  2010-08-12       Impact factor: 4.102

5.  In silico analysis of the binding of agonists and blockers to the β2-adrenergic receptor.

Authors:  Santiago Vilar; Joel Karpiak; Barkin Berk; Stefano Costanzi
Journal:  J Mol Graph Model       Date:  2011-01-19       Impact factor: 2.518

6.  Structure based prediction of subtype-selectivity for adenosine receptor antagonists.

Authors:  Vsevolod Katritch; Irina Kufareva; Ruben Abagyan
Journal:  Neuropharmacology       Date:  2010-07-15       Impact factor: 5.250

7.  Structure of a nanobody-stabilized active state of the β(2) adrenoceptor.

Authors:  Søren G F Rasmussen; Hee-Jung Choi; Juan Jose Fung; Els Pardon; Paola Casarosa; Pil Seok Chae; Brian T Devree; Daniel M Rosenbaum; Foon Sun Thian; Tong Sun Kobilka; Andreas Schnapp; Ingo Konetzki; Roger K Sunahara; Samuel H Gellman; Alexander Pautsch; Jan Steyaert; William I Weis; Brian K Kobilka
Journal:  Nature       Date:  2011-01-13       Impact factor: 49.962

Review 8.  Therapeutic potential of β-arrestin- and G protein-biased agonists.

Authors:  Erin J Whalen; Sudarshan Rajagopal; Robert J Lefkowitz
Journal:  Trends Mol Med       Date:  2010-12-21       Impact factor: 11.951

9.  The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptor.

Authors:  Tony Warne; Rouslan Moukhametzianov; Jillian G Baker; Rony Nehmé; Patricia C Edwards; Andrew G W Leslie; Gebhard F X Schertler; Christopher G Tate
Journal:  Nature       Date:  2011-01-13       Impact factor: 49.962

10.  Structure and function of an irreversible agonist-β(2) adrenoceptor complex.

Authors:  Daniel M Rosenbaum; Cheng Zhang; Joseph A Lyons; Ralph Holl; David Aragao; Daniel H Arlow; Søren G F Rasmussen; Hee-Jung Choi; Brian T Devree; Roger K Sunahara; Pil Seok Chae; Samuel H Gellman; Ron O Dror; David E Shaw; William I Weis; Martin Caffrey; Peter Gmeiner; Brian K Kobilka
Journal:  Nature       Date:  2011-01-13       Impact factor: 49.962

View more
  178 in total

1.  Secretin family (Class B) G protein-coupled receptors - from molecular to clinical perspectives.

Authors:  David R Poyner; Debbie L Hay
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  Critical features for biosynthesis, stability, and functionality of a G protein-coupled receptor uncovered by all-versus-all mutations.

Authors:  Karola M Schlinkmann; Annemarie Honegger; Esin Türeci; Keith E Robison; Daša Lipovšek; Andreas Plückthun
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-04       Impact factor: 11.205

3.  New insights into the stereochemical requirements of the bradykinin B2 receptor antagonists binding.

Authors:  Cecylia S Lupala; Patricia Gomez-Gutierrez; Juan J Perez
Journal:  J Comput Aided Mol Des       Date:  2015-12-24       Impact factor: 3.686

Review 4.  Structural approaches to understanding retinal proteins needed for vision.

Authors:  Tivadar Orban; Beata Jastrzebska; Krzysztof Palczewski
Journal:  Curr Opin Cell Biol       Date:  2013-11-28       Impact factor: 8.382

5.  Coordinating the impact of structural genomics on the human α-helical transmembrane proteome.

Authors:  Ursula Pieper; Avner Schlessinger; Edda Kloppmann; Geoffrey A Chang; James J Chou; Mark E Dumont; Brian G Fox; Petra Fromme; Wayne A Hendrickson; Michael G Malkowski; Douglas C Rees; David L Stokes; Michael H B Stowell; Michael C Wiener; Burkhard Rost; Robert M Stroud; Raymond C Stevens; Andrej Sali
Journal:  Nat Struct Mol Biol       Date:  2013-02       Impact factor: 15.369

6.  Structure of the human angiotensin II type 1 (AT1) receptor bound to angiotensin II from multiple chemoselective photoprobe contacts reveals a unique peptide binding mode.

Authors:  Dany Fillion; Jérôme Cabana; Gaétan Guillemette; Richard Leduc; Pierre Lavigne; Emanuel Escher
Journal:  J Biol Chem       Date:  2013-02-05       Impact factor: 5.157

7.  Structural Connection between Activation Microswitch and Allosteric Sodium Site in GPCR Signaling.

Authors:  Kate L White; Matthew T Eddy; Zhan-Guo Gao; Gye Won Han; Tiffany Lian; Alexander Deary; Nilkanth Patel; Kenneth A Jacobson; Vsevolod Katritch; Raymond C Stevens
Journal:  Structure       Date:  2018-01-27       Impact factor: 5.006

8.  β2-Adrenergic receptor solutions for structural biology analyzed with microscale NMR diffusion measurements.

Authors:  Reto Horst; Pawel Stanczak; Raymond C Stevens; Kurt Wüthrich
Journal:  Angew Chem Int Ed Engl       Date:  2012-10-24       Impact factor: 15.336

Review 9.  2016 Scientific Sessions Sol Sherry Distinguished Lecturer in Thrombosis: Thrombotic Stroke: Neuroprotective Therapy by Recombinant-Activated Protein C.

Authors:  John H Griffin; Laurent O Mosnier; José A Fernández; Berislav V Zlokovic
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-10-06       Impact factor: 8.311

10.  Isothermal chemical denaturation to determine binding affinity of small molecules to G-protein coupled receptors.

Authors:  Patrick Ross; Wilhelm Weihofen; Fai Siu; Amy Xie; Hetal Katakia; S Kirk Wright; Ian Hunt; Richard K Brown; Ernesto Freire
Journal:  Anal Biochem       Date:  2014-12-04       Impact factor: 3.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.